Sangamo Biosciences reported $0 in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US $ 676.71M 1.01M
Amgen AMGN:US $ 36010M 2788M
Avrobio Inc AVRO:US $ 15.02M 75K
Bayer BAYN:GR € 36648M 167M
Biocryst Pharmaceuticals BCRX:US $ 604.46M 19M
Biogen BIIB:US $ 6275.7M 1.7M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Gilead Sciences GILD:US $ 25183M 4M
GlaxoSmithKline GSK:LN 29226M 8654M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
IONIS PHARMACEUT IONS:US $ 1247.93M 19.91M
Johnson & Johnson JNJ:US $ 28851M 1134M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Merk MRK:US $ 30586M 104M
Novartis NOVN:VX SF 24373M 150M
Omeros OMER:US $ 313.9M 131K
Pfizer PFE:US $ 35656M 539M
Regulus Therapeutics RGLS:US $ 3.59M 1.08M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.41M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
Ziopharm Oncology ZIOP:US $ 10.32M 5.93M